Tumor angiogenesis as a prognostic predictor in pancreatic cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 5, 2000, Pages 489-495

  Karademir, Sedat ^a   Sökmen, Selman ^a   Terzi, Cem ^a   Saǧol, Özgül ^a   Özer, Erdener ^a   Astarcioǧlu, Hüseyin ^a   Çoker, Ahmet ^a   Astarcioǧlu, Ibrahim ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Pancreatic cancer; Surgery; Survival

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; RAS PROTEIN;

ADENOCARCINOMA; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PANCREAS DUCT; PANCREAS TUMOR; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TIME; VASCULARIZATION;

ADENOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RAS PROTEINS; SURVIVAL RATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034576723     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340070020     Document Type: Article

References (42)

1. Capella G, Villanueva A, Erill N, Lluis F (1996) Molecular epidemiology of protooncogene and tumor-suppressor gene mutations. In: Neoptolemos JP, Lemoine NR (eds) Pancreatic cancer: molecular and clinical advances. Blackwell Science, Oxford, pp 169-180
2. Compton CC, Mulvihill SJ (1997) Prognostic factors in pancreatic carcinoma. Surg Oncol Clin North Am 6:533-554
3. Yeo CJ, Cameron JL (1999) Pancreatic cancer. Curr Prob Surg 36:66-152
4. Hahn SA, Kern SE (1995) Molecular genetics of exocrine pancreatic neoplasms. Surg Clin North Am 75:857-869
5. Friess H, Kleeff J, Kore M, Buchler MW (1999) Molecular aspects of pancreatic cancer and future perspectives. Dig Surg 16:281-290
6. Levine AJ (1997) p53, The cellular gatekeeper for growth and division. Cell 88:323-331
7. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
8. Folkman J (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
9. Hanahan D, Folkman (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
10. Gasparini G, Presta M (1996) Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. Ann Oncol 7:441-444
11. Craft PS, Harris AL (1994) Clinical prognostic significance of tumour angiogenesis. Ann Oncol 5:305-311
12. van Hinsbergh VW, Collen A, Koolwijk P (1999) Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors. Ann Oncol 10 (Suppl 4):60-63
13. Goggins M, Kern SE, Offerhaus JA, Hruban RH (1999) Progress in cancer genetics: lessons from pancreatic cancer. Ann Oncol 10 (Suppl 4):4-8
14. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
15. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ (1986) Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 22:1205-1209
16. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409
17. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA (1992) Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340:145-146
18. Choi HJ, Hyun MS, Jung GJ, Kim SS, Kong SH (1998) Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 55:575-581
19. Lindmark G, Gerdin B, Sundberg C, Pahlman L, Bergstrom R, Glimelius B (1996) Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 14:461-466
20. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82-86
21. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466
22. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW (eds) (1997) Exocrine pancreas. The American Joint Committee on Cancer staging manual, 5th edn. Lippincott-Raven, Philadelphia, pp 121-126
23. Jass JR, Sobin LH, Watanabe H (1990) The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 66:2162-2167
24. Gilcrease MZ, Truong L, Brown RW (1996) Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas. Hum Pathol 2:1355-1360
25. Barth PJ, Weingartner K, Kohler HH, Bittinger A (1996) Assessment of the vascularization in prostatic carcinoma: a morphometric investigation. Hum Pathol 27:1306-1310
26. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB (1998) Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 34:337-340
27. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kapehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553-1563
28. Egawa S, Tsutsumi M, Konishi Y, Kobari M, Matsuno S, Nagasaki K, Futami H, Yamaguchi K (1995) The role of angiogeneis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR. Gastroenterology 108:1526-1533
29. Kawarada Y, Ishikura H, Kishimoto T, Saito K, Takahashi T, Kato H, Yoshiki T (1997) Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo. Pancreas 15:251-257
30. Gilliland R, Williamson K, Wilson R, Anderson N, Hamilton P (1996) Colorectal cell kinetics. Br J Surg 83:739-749
31. Tubiana M, Pejovic M, Koscielny S, Chvauda N, Malasia E (1989) Growth rate, kinetics of tumor cell proliferation and long term outcome in human breast cancer. Int J Cancer 44:17-22
32. Texeira C, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G (1994) Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinoma. Cancer 73:575-579
33. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H (1993) The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor and mdr gene expression in colorectal cancer. Cancer 71:2454-2460
34. Ferrara C, Tessari G, Poletti A, Giacon C, Meggiato T, Martines D, Del Favero G, Naccarato R (1999) Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 6:1117-1122
35. Makinen K, Hakala T, Lipponen P, Alhava E, Eskelinen M (1998) Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Anticancer Res 18:615-618
36. Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C (1995) Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res 15:2659-2668
37. Bos JL (1989) ras Oncogenes in human cancer: A review. Cancer Res 49:4682-4689
38. Kalthoff H, Schmiegel W (1993) p53 and K-ras alterations in pancreatic epithelial cell lesions. Oncogene 8:289-298
39. Waldmann V, Rabes HM (1996) What's new in ras genes? Physiological role of ras genes in signal transduction and significance of ras gene activation in tumorigenesis. Pathol Res Pract 192:883-891
40. Wanebo HJ, Vezeredis MP (1996) Pancreatic carcinoma in perspective. A continuing challenge. Cancer 78:580-591
41. Giambernardi TA, Grant GM, Taylor GP, Hay RJ Maher UM, McCormick JJ, Klebe RJ (1998) Overview of matrix metalloproteinase expression in cultured human cell. Matrix Biol 16:483-496
42. Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jarcono JL (1996) Up-regulation of vascular endothelial growth/vascular permeability factor in mouse skin carcinogenesis correlated with malignant progression state and activated H-ras expression levels. Cancer Res 56:5395-5396